Ditchcarbon
  • Customers
  1. Organizations
  2. Tty Biopharm
Public Profile
Pharmaceutical Preparation Manufacturing
TW
updated 18 days ago

Tty Biopharm

Company website

Tty Biopharm Corporation, commonly referred to as Tty Biopharm, is a prominent player in the biopharmaceutical industry, headquartered in Taiwan (TW). Founded in 1966, the company has established itself as a leader in the development and manufacturing of innovative pharmaceuticals, particularly in oncology and other therapeutic areas. With a strong presence in both domestic and international markets, Tty Biopharm is renowned for its commitment to quality and research-driven solutions. The company’s core offerings include a diverse range of generic and proprietary medications, distinguished by their efficacy and safety profiles. Notable achievements include strategic partnerships and a robust pipeline of products that cater to unmet medical needs, solidifying Tty Biopharm's position as a trusted name in the biopharmaceutical landscape.

DitchCarbon Score

How does Tty Biopharm's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

37

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

28

Industry Benchmark

Tty Biopharm's score of 37 is higher than 62% of the industry. This can give you a sense of how well the company is doing compared to its peers.

62%

Let us know if this data was useful to you

Tty Biopharm's reported carbon emissions

In 2023, Tty Biopharm, headquartered in Taiwan (TW), reported total carbon emissions of approximately 10,000,000 kg CO2e. This figure includes 1,700,218 kg CO2e from Scope 1 emissions, 8,488,804 kg CO2e from Scope 2 emissions, and 2,549,524 kg CO2e from Scope 3 emissions. The company has shown a commitment to transparency by disclosing emissions across all three scopes. Comparatively, in 2022, Tty Biopharm's emissions were about 9,000,000 kg CO2e, with Scope 1 at 1,535,317 kg CO2e, Scope 2 at 8,232,490 kg CO2e, and Scope 3 at 3,041,935 kg CO2e. This indicates a slight increase in total emissions year-on-year. Despite the increase in emissions, Tty Biopharm has not set specific reduction targets or initiatives as part of their climate commitments. The company has not cascaded any emissions data from a parent organization, maintaining its own reporting standards. Overall, Tty Biopharm's emissions data reflects its operational impact, and while no formal reduction targets are in place, the company continues to monitor and report its carbon footprint.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

20162017201820192020202120222023
Scope 1
-
000,000
0,000,000
000,000
000,000
000,000
0,000,000.0
0,000,000.0
Scope 2
-
0,000,000
0,000,000
0,000,000
0,000,000
0,000,000
0,000,000.0
0,000,000.0
Scope 3
625,000
-
-
-
-
-
0,000,000.0
0,000,000.0

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Tty Biopharm's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Tty Biopharm is in TW, which we do not have grid emissions data for.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Tty Biopharm is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Sanofi

FR
•
Pharmaceutical Preparation Manufacturing
Updated about 14 hours ago

Johnson And Johnson

US
•
Pharmaceutical Preparation Manufacturing
Updated about 2 hours ago

Astra Zeneca

GB
•
Pharmaceutical Preparation Manufacturing
Updated about 2 hours ago

Cspc Pharmaceutical

HK
•
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Abbott

US
•
Medical, precision and optical instruments, watches and clocks (33)
Updated 31 minutes ago

Astra Tech GesmbH (Austria)

AT
Updated about 1 month ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v250828.3
enquiries@ditchcarbon.com+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
Verified byUL Verified
Partnered withCDP
ProductPortalDataDocumentationIntegrationsChangelogPricing
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesMethodologyBlogFAQOrganizationsIndustriesSBTI APITrust Centre
AboutTeamCareersLicense AgreementPrivacy